Combination therapy with ruxolitinib plus 5-azacytidine or continuous infusion of low dose cytarabine is feasible in patients with blast-phase myeloproliferative neoplasms

2014

Keywords: myeloproliferative neoplasms; blast phase; hypomethylating agents; Janus Kinase inhibitors

Keywords:

References

Citations